PubRank

I Hayakawa

Author PubWeight™ 51.69‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates. Antimicrob Agents Chemother 1992 4.43
2 Synthesis and antibacterial activities of optically active ofloxacin. Antimicrob Agents Chemother 1986 2.74
3 Inhibition of DNA gyrase by optically active ofloxacin. Antimicrob Agents Chemother 1987 2.03
4 Synthesis and antibacterial activities of substituted 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxyl ic acids. Chem Pharm Bull (Tokyo) 1984 1.99
5 Inhibition by quinolones of DNA gyrase from Staphylococcus aureus. Antimicrob Agents Chemother 1991 1.93
6 Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A 1990 1.87
7 Antimicrobial activity of DV-7751a, a new fluoroquinolone. Antimicrob Agents Chemother 1993 1.86
8 Contribution of the C-8 substituent of DU-6859a, a new potent fluoroquinolone, to its activity against DNA gyrase mutants of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995 1.84
9 Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus. Antimicrob Agents Chemother 1997 1.70
10 The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis. Br J Dermatol 2008 1.22
11 Mechanisms of 4-quinolone resistance in quinolone-resistant and methicillin-resistant Staphylococcus aureus isolates from Japan and China. J Med Microbiol 1995 1.21
12 Passive Heymann nephritis with acute and severe proteinuria induced by heterologous antibody against renal tubular brush border glycoprotein gp108. Lab Invest 1986 1.08
13 Mechanism of differential activities of ofloxacin enantiomers. Antimicrob Agents Chemother 1996 1.07
14 Significance of the methyl group on the oxazine ring of ofloxacin derivatives in the inhibition of bacterial and mammalian type II topoisomerases. Antimicrob Agents Chemother 1991 1.07
15 Antimicrobial activity of DU-6681a, a parent compound of novel oral carbapenem DZ-2640. Antimicrob Agents Chemother 1997 1.06
16 Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis. Rheumatology (Oxford) 2004 1.05
17 Effect of growth conditions on antimicrobial activity of DU-6859a and its bactericidal activity determined by the killing curve method. J Antimicrob Chemother 1996 0.97
18 Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases. Antimicrob Agents Chemother 1998 0.95
19 Identification of gp108, a pathogenic antigen of passive Heymann nephritis, as dipeptidyl peptidase IV. Clin Exp Immunol 1987 0.94
20 Effect of feed gas composition of gas discharge plasmas on Bacillus pumilus spore mortality. Lett Appl Microbiol 2003 0.93
21 The influence of dissolved CO(2) concentration on the death kinetics of Saccharomyces cerevisiae. J Appl Microbiol 2001 0.92
22 Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis. Clin Exp Immunol 2004 0.90
23 The detection and characterization of renal brush border antigen (gp108) in various rat tissues. Clin Exp Immunol 1987 0.86
24 Role of dipeptidyl peptidase IV (gp 108) in passive Heymann nephritis. Use of dipeptidyl peptidase IV-deficient rats. Am J Pathol 1989 0.86
25 (Fluorocyclopropyl)quinolones. 2. Synthesis and Stereochemical structure-activity relationships of chiral 7-(7-amino-5-azaspiro[2.4]heptan-5-yl)-1-(2-fluorocyclopropyl)quinolone antibacterial agents. J Med Chem 1994 0.85
26 Diploic fibroma of the skull. Surg Neurol 1978 0.85
27 Fluorocyclopropyl quinolones. 1. Synthesis and structure-activity relationships of 1-(2-fluorocyclopropyl)-3-pyridonecarboxylic acid antibacterial agents. J Med Chem 1993 0.85
28 Possible intermolecular interaction between quinolones and biphenylacetic acid inhibits gamma-aminobutyric acid receptor sites. Antimicrob Agents Chemother 1994 0.82
29 Mechanism of the inactivation of bacterial spores by reciprocal pressurization treatment. J Appl Microbiol 2003 0.82
30 Study on early re-rupture of intracranial aneurysms. Acta Neurochir (Wien) 1996 0.82
31 Perangiographic rupture of intracranial aneurysms. Neuroradiology 1978 0.81
32 Synthesis and antibacterial activities of optically active ofloxacin and its fluoromethyl derivative. Chem Pharm Bull (Tokyo) 1987 0.80
33 Synthesis and structure-activity relationships of 7-[3-(1-aminoalkyl)pyrrolidinyl]- and 7-[3-1-aminocycloalkyl)pyrrolidinyl]-quinolone antibacterials. Chem Pharm Bull (Tokyo) 1994 0.80
34 [Analysis of 223 cases of intracranial aneurysms--with special reference to re-rupture of the intracranial aneurysms]. No Shinkei Geka 1983 0.80
35 Anti-phosphatidylserine-prothrombin complex antibodies in patients with localized scleroderma. Clin Exp Rheumatol 2006 0.78
36 Rerupture of intracranial aneurysms during angiography. Acta Neurochir (Wien) 1989 0.78
37 Radiotherapy for pediatric brain stem glioma: radiation dose, response, and survival. Neurosurgery 1992 0.78
38 Soft denture liner of fluoroethylene copolymer and its clinical evaluation. J Prosthet Dent 1984 0.78
39 Analysis of 223 ruptured intracranial aneurysms with special reference to rerupture. Surg Neurol 1984 0.77
40 [Choroid plexus carcinoma with metastasis to bone (author's transl)]. No Shinkei Geka 1979 0.77
41 Synthesis and antibacterial activity of novel pyridobenzoxazine analogues. Chem Pharm Bull (Tokyo) 1998 0.77
42 Effect of electrical stimulation on the rheological properties of rabbit skeletal muscle. Meat Sci 1991 0.77
43 A histological and electron-microscopic study of the cell types involved in rejection of skin allografts in ammocoetes. Cell Tissue Res 1983 0.77
44 [Craniopharyngioma with malignant transformation--a report of two cases]. Gan No Rinsho 1989 0.77
45 Quantification of oxidative metabolism in masseter muscle of denture wearers. Clin Oral Investig 2005 0.76
46 Heymann nephritis in rats induced by human renal tubular antigens: characterization of antigen and antibody specificities. Clin Exp Immunol 1987 0.76
47 The role of oral sensorimotor function in masticatory ability. J Oral Rehabil 2004 0.76
48 Accelerated death kinetics of Aspergillus niger spores under high-pressure carbonation. Appl Environ Microbiol 2002 0.75
49 [Unusual recurrence of an IC--PC aneurysm after neck clipping--any structural weakness of the clip? (author's transl)]. Acta Neurochir (Wien) 1976 0.75
50 [Early history of regional public health nursing activities in Kyoto, leading to the establishment of the home visit system]. Hokenfu Zasshi 1976 0.75
51 [FAR therapy in brain tumors--FT207-vitamin A-Radiation therapy (author's transl)]. Neurol Med Chir (Tokyo) 1980 0.75
52 [Interhemispheric subdural empyema diagnosed by CT and cured by antibiotic therapy (author's transl)]. Rinsho Shinkeigaku 1981 0.75
53 [Medical care given by the Horikawa Hospital, Kyoto, and its close relationship with the local residents]. Kangogaku Zasshi 1981 0.75
54 Evaluation with the BacT/ALERT microbial detection system of bacterial contamination in autologous blood donation and transfusion. Transfus Med 2011 0.75
55 [Clinical studies on head injuries in infants]. No To Shinkei 1970 0.75
56 [Experience with radio isotope myelography from neurosurgical aspects (author's transl)]. No Shinkei Geka 1976 0.75
57 Short storage studies on the effect of temperature and relative humidity on the viability of airborne bacteria. Am Ind Hyg Assoc J 1965 0.75
58 [Spontaneous regression of sinus pericranii--report of a case (author's transl)]. No Shinkei Geka 1978 0.75
59 Experimental transplantation of the head--two headed dog. Neurol Med Chir (Tokyo) 1964 0.75
60 [Surgical treatment of the orbital blow-out fracture (author's transl)]. No Shinkei Geka 1976 0.75
61 [Hemangioblastoma of the cauda equina--a case report (author's transl)]. No Shinkei Geka 1978 0.75
62 Nephritogenic glycoprotein. XIII. Isolation and its immunochemical characterization of the antigenic substance of membranous glomerulonephritis induced by a single injection of crude nephritogenoside in homologous animals. Nephron 1989 0.75
63 [Clinical use of a new soft facing material (soft fluoro-polymer)]. Shikai Tenbo 1979 0.75
64 [Dental occlusion and loose fitting dentures]. Shikai Tenbo 1984 0.75
65 [Modern neurosurgical facilities in West Germany]. No To Shinkei 1971 0.75
66 [Inappropriate secretion of antidiuretic syndrome with positive ADH bioassay]. No To Shinkei 1969 0.75
67 [Use of adhesive resins in dentures with stainless steel bases]. Shikai Tenbo 1984 0.75
68 Synthesis of antimicrobial agents. VII. Synthesis and antibacterial activities of furo [2,3-g]quinoline derivatives. Chem Pharm Bull (Tokyo) 1984 0.75
69 [A case of complete dentures for total anodontia]. Kokubyo Gakkai Zasshi 1972 0.75
70 [Home visits by public health nurses leading to the establishment of a local hospital in Kyoto]. Hokenfu Zasshi 1976 0.75
71 [The clinical significance of vascular compression in trigeminal neuralgia and hemifacial spasm (author's transl)]. No Shinkei Geka 1981 0.75
72 [Diagnosis and management of external hydrocephalus--transition from external to internal hydrocephalus]. No To Hattatsu 1983 0.75
73 [Factors affecting pulmonary arterial carbon dioxide concentration (Paco2) during artificial ventilation with general anesthesia]. Masui 1976 0.75
74 [Department of Neurosurgery, Bonn University]. No To Shinkei 1968 0.75
75 [Surgical treatment of hemifacial spasm associated with tortuous vertebrobasilar system (author's transl)]. No Shinkei Geka 1978 0.75
76 [Hallucinose pédonculaire in a patient with localized midbrain hemorrhage caused by arterio-venous malformation]. Rinsho Shinkeigaku 1984 0.75
77 [Metallurgical study on Heifetz clip failure (author's transl)]. No Shinkei Geka 1982 0.75
78 [Development of a soft denture liner (dough-type) using a fluoroethylene copolymer]. Nihon Hotetsu Shika Gakkai Zasshi 1986 0.75
79 [Acute subdural hematoma in infancy and childhood; its clinical investigation (author's transl)]. No Shinkei Geka 1975 0.75
80 Tritium labeling of insulin and its application to the double isotope derivative dilution analysis. Chem Pharm Bull (Tokyo) 1977 0.75
81 [Use of soft denture liner, Crepet, for denture bases and some clinical cases]. DE J Dent Eng 1981 0.75
82 [The method to accomplish registration of jaw relation records from the edentulous patient (author's transl)]. Shikai Tenbo 1982 0.75
83 Cerebral retroflexion in holoprosencephaly developed following ventriculo-peritoneal shunting: a case report. Surg Neurol 1993 0.75
84 [Clinical application of an absorbable substitute for the dura mater--with special reference to gelatin]. Shujutsu 1967 0.75
85 [Cerebral ischemic lesions in children and primary cerebral angiitis: report of two cases]. No Shinkei Geka 1986 0.75
86 [Transplantation of the head]. No To Shinkei 1966 0.75
87 [A fundamental study of the calcification and resorption of alveolar bone]. Kokubyo Gakkai Zasshi 1970 0.75
88 [Study of ruptured intracranial aneurysms with intracerebral hematomas--with special reference to operative indication]. No Shinkei Geka 1985 0.75
89 Toxicological evaluation and disposition of DV-7751a, a new quinolone antimicrobial agent, administered orally to dogs and monkeys. Chemotherapy 1997 0.75
90 [Clinical studies on a new intracranial pressure reducing agent]. Zentralbl Neurochir 1967 0.75
91 [Brain tumor and cyclic nucleotides. I. Concentrations of cyclic AMP and cyclic GMP in various brain tumors (author's transl)]. No To Shinkei 1980 0.75
92 [Tissue conditioning--conditioning of oral mucosa]. Hotetsu Rinsho 1981 0.75
93 Recent advances in the field of quinolones. Farmaco 2001 0.75
94 [Development of a light curing denture base resin]. Shika Zairyo Kikai 1989 0.75
95 [Some problems with denture prosthesis for the aged]. Nihon Shika Ishikai Zasshi 1978 0.75
96 [Blood concentration and urinary excretion of intravenously administered succinyldicholine]. Masui 1971 0.75
97 Synthesis of antimicrobial agents. VI. Studies on the synthesis of furo[3,2-b][1,8]naphthyridine derivatives. Chem Pharm Bull (Tokyo) 1984 0.75
98 Structure-activity relationship of HIV-1 protease inhibitors containing alpha-hydroxy-beta-amino acids. Detailed study of P1 site. Bioorg Med Chem 1999 0.75
99 [Formation of traumatic aneurysm of carotid artery following treatment of carotid-cavernous fistula with muscle embolization]. Acta Neurochir (Wien) 1972 0.75
100 [An infantile intracranial peripheral aneurysm accompanied by acute subdural hematoma (author's transl)]. No Shinkei Geka 1974 0.75
101 [Traumatic delayed intracerebral hematoma--clinical aspects]. No Shinkei Geka 1985 0.75
102 [Clinical study of spinal intradural arachnoid cyst]. No Shinkei Geka 1985 0.75
103 [The possibility of drug design of quinolones effective for multiresistant gram-positive pathogens]. Nihon Rinsho 1997 0.75